Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohammed Hadi Munshed Alosami"'
Publikováno v:
Bionatura. 8:1-6
Rheumatoid arthritis is a worldwide inflammatory chronic autoimmune disease with varying severity. Due to no definitive cure for this disease, current therapies aim to decrease the pain and slow further damage. The interleukin (IL)‐36 cytokine was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::60c5d5fcb6fb6641a3cc65d838ea936e
https://doi.org/10.21931/rb/2023.08.01.53
https://doi.org/10.21931/rb/2023.08.01.53
Publikováno v:
Rheumatology (Bulgaria). 30:3-11
Background: Axial spondyloarthritis (axSpA) is an inflammatory, systemic rheumatic condition that mostly affects the axial skeleton. Tenascin-C (TN-C) is a hexameric glycoprotein of considerable size, upregulated in many inflammatory conditions, whil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d01f82434a78359d235990d110c9a914
https://doi.org/10.35465/30.4.2022.pp3-11
https://doi.org/10.35465/30.4.2022.pp3-11
Autor:
null Wafaa Tialp Mohammed, null Mohammed Hadi Munshed Alosami, null Alia Essam Mahmood Alubadi
Publikováno v:
Biomedicine. 42:699-702
Introduction and Aim: The pro-inflammatory cytokine IL-39, a member of the IL-12 family plays a key role in the inflammatory response by modulating immune cell activity and inflammation. A literature search shows no study undertaken for the effect of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bee0440c1d65c8efd49745292e1c99b
https://doi.org/10.51248/.v42i4.1866
https://doi.org/10.51248/.v42i4.1866
Publikováno v:
Indian Journal of Clinical Biochemistry.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5fc0adf87bd4b2f3bf7f5dcbf14bf31
https://doi.org/10.1007/s12291-023-01124-5
https://doi.org/10.1007/s12291-023-01124-5
Publikováno v:
F1000Research. 11:1047
Background: Rheumatoid arthritis (RA) is a chronically progressing inflammatory disease having articular, extra-articular, and systemic manifestations of unclear origin. Medication-related burden (MRB) is a novel concept that focuses on unpleasant fe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef90e2e674d752e82d76e9c7f878c519
https://doi.org/10.12688/f1000research.125446.1
https://doi.org/10.12688/f1000research.125446.1